MedTrace Logo

A Retrospective Chart Review Study of Gene-Eden-VIR/Novirin

NCT02715752 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2016-04-26

No results posted yet for this study

Summary

This study measured the changes in health-related complaints by analyzing charts of individuals, who are infected with a latent virus, who have used Gene-Eden-VIR/Novirin.

Conditions

  • Herpes Simplex Infections
  • Human Papillomavirus
  • Epstein-Barr Virus Infections
  • Varicella-zoster Virus Infection
  • Cytomegalovirus Infections

Interventions

DIETARY_SUPPLEMENT

Gene-Eden-VIR/Novirin

Sponsors & Collaborators

  • The Center for the Biology of Chronic Disease

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02715752 on ClinicalTrials.gov